Can Hong Kong serve as the bridge for the development of biotech in mainland China?
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Sino-US Drug Development Forum, organized by the Chinese Biopharmaceutical Association USA (Washington, DC, November 9, 2005). http://www.cba-usa.org/html/SUDDF_102105.pdf
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wong, G. Chinese biotech: the need for innovation and higher standards. Nat Biotechnol 24, 221–222 (2006). https://doi.org/10.1038/nbt0206-221
Issue Date:
DOI: https://doi.org/10.1038/nbt0206-221
This article is cited by
-
Can China's supply of scientific talent keep up with demand?
Nature Biotechnology (2008)